These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6997706)

  • 1. Fatty acids, fibrinogen and blood flow: a general mechanism for hyperfibrinogenemia and its pathologic consequences.
    Pickart LR; Thaler MM
    Med Hypotheses; 1980 May; 6(5):545-57. PubMed ID: 6997706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of tumor-associated hyperfibrinogenemia and free fatty acidemia with p-phenoxybenzalbutyrate (clofibrate).
    Pickart L; Thaler MM
    Cancer Res; 1979 Oct; 39(10):3845-8. PubMed ID: 476620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free fatty acids and albumin as mediators of thrombin-stimulated fibrinogen synthesis.
    Pickart LR; Thaler MM
    Am J Physiol; 1976 Apr; 230(4):996-1002. PubMed ID: 1267031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free fatty acidemia as an inducer of systemic hyperfibrinogenemia and fibrinolytic inhibition.
    Pickart L
    Inflammation; 1981 Mar; 5(1):61-70. PubMed ID: 6971806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in flow properties of the blood in pregnancy].
    Heilmann L
    Zentralbl Gynakol; 1986; 108(7):393-402. PubMed ID: 3716677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fat metabolism, the fibrinogen/fibrinolytic system and blood flow: new potentials for the pharmacological treatment of coronary heart disease.
    Pickart L
    Pharmacology; 1981; 23(5):271-80. PubMed ID: 7027278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of blood flow on fatty acid mobilization form lipolytically active adipose tissue.
    Bülow J; Madsen J
    Pflugers Arch; 1981 May; 390(2):169-74. PubMed ID: 7195565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of fibrinogen biosynthesis: role of the FFA/albumin ratio.
    Pilgeram L
    Cardiovasc Eng; 2010 Jun; 10(2):78-83. PubMed ID: 20383582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of acute-phase synthesis of fibrinogen by a hypolipidemic drug (clofibrate).
    Pickart L
    Int J Tissue React; 1981 Jun; 3(2):65-72. PubMed ID: 7327616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum fatty acid/albumin molar ratio and the risk of diseases.
    Høstmark AT
    Med Hypotheses; 1995 Jun; 44(6):539-41. PubMed ID: 7476603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression.
    Cordido F; Peino R; Peñalva A; Alvarez CV; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1996 Mar; 81(3):914-8. PubMed ID: 8772550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
    Julius U
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids.
    Pontiroli AE; Manzoni MF; Malighetti ME; Lanzi R
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3998-4001. PubMed ID: 8923850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of in vivo increase of free fatty acids on human plasma protein binding of furosemide.
    Colombo R; Pinelli A
    Pharmacology; 1982; 25(2):73-81. PubMed ID: 7134262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of fasting plasma free fatty acid concentration and frequency of ventricular premature complexes in nonischemic non-insulin-dependent diabetic patients.
    Paolisso G; Gualdiero P; Manzella D; Rizzo MR; Tagliamonte MR; Gambardella A; Verza M; Gentile S; Varricchio M; D'Onofrio F
    Am J Cardiol; 1997 Oct; 80(7):932-7. PubMed ID: 9382011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of decreasing plasma free fatty acids by acipimox on hepatic glucose metabolism in normal rats.
    Lee KU; Park JY; Kim CH; Hong SK; Suh KI; Park KS; Park SW
    Metabolism; 1996 Nov; 45(11):1408-14. PubMed ID: 8931647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acipimox-mediated plasma free fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli.
    Peino R; Cordido F; Peñalva A; Alvarez CV; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1996 Mar; 81(3):909-13. PubMed ID: 8772549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocyte crenation induced by free fatty acids in patients undergoing extracorporeal circulation.
    Kamada T; McMillan DE; Sternlieb JJ; Bjork VO; Otsuji S
    Lancet; 1987 Oct; 2(8563):818-21. PubMed ID: 2889031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of free fatty acids on the concentration of free thyroxine in human serum: the role of albumin.
    Mendel CM; Frost PH; Cavalieri RR
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1394-9. PubMed ID: 3782424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
    Imura H; Kato Y; Ikeda M; Morimoto M; Yawata M
    J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.